Serine/threonine protein kinase (H-SGK2)
OwnerSanjay Kumar, Cheng Zouinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerSanjay Kumar, Cheng Zouinventors
Estimating the term…
H-SGK2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing H-SGK2 polypeptides and polynucleotides in the design of protocols for the treatment of chronic and acute inflammation, arthritis, osteoarthritis, septicemia, autoimmune diseases (e.g., inflammatory bowel disease, psoriasis), transplant rejection, graft vs. host disease, infection, stroke, ischemia, acute respiratory disease syndrome, renal disorders, restenosis, brain injury, AIDS, metabolic and other bone diseases (e.g., osteoporosis), cancer (e.g., lymphoproliferative disorders), atherosclerosis, and Alzheimers disease, among others, and diagnostic assays for such conditions.
An isolated polynucleotide comprising a nucleotide sequence that has at least 80% identity over its entire length to a nucleotide sequence encoding the H-SGK2 polypeptide of SEQ ID NO:
A DNA or RNA molecule comprising an expression system, wherein said expression system is capable of producing a H-SGK2 polypeptide comprising an amino acid sequence, which has at least 80% identity with the polypeptide of SEQ ID NO:
A H-SGK2 polypeptide comprising an amino acid sequence which is at least 80% identical to the amino acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.